Itamar's first two product lines based on the PAT signal are WatchPAT, a home device for the diagnosis of sleep apnea and EndoPAT, a device testing endothelial function, the only one approved by the FDA, designed to test endothelial dysfunction at an early stage and diagnose coronary artery disease and other cardiovascular disease.